Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Saral

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Microbiology|May 1, 1995
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplificationF S Nolte, R K Emmens, C Thurmond, et al.
Blood|September 1, 1995
CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1T F Neal, H K Holland, C M Baum, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|October 1, 1991
Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive diseaseJ R Wingard, C S Niehaus, D E Peterson, et al.
Annals of Internal Medicine|January 1, 1987
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trialJ E Karp, W G Merz, C Hendricksen, et al.
Transplantation Proceedings|December 1, 1987
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxisA D Donnenberg, A D Hess, S C Duff, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986
Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tractJ E Karp, W G Merz, C Hendricksen, et al.
Bone Marrow Transplantation|November 1, 1989
Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipientsJ R Wingard, E D Mellits, R J Jones, et al.
The New England Journal of Medicine|July 1, 1982
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipientsG V Quinnan, N Kirmani, A H Rook, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationL B Grochow, R J Jones, R B Brundrett, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|May 1, 1995
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplificationF S Nolte, R K Emmens, C Thurmond, et al.
Blood|September 1, 1995
CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1T F Neal, H K Holland, C M Baum, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|October 1, 1991
Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive diseaseJ R Wingard, C S Niehaus, D E Peterson, et al.
Annals of Internal Medicine|January 1, 1987
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trialJ E Karp, W G Merz, C Hendricksen, et al.
Transplantation Proceedings|December 1, 1987
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxisA D Donnenberg, A D Hess, S C Duff, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986
Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tractJ E Karp, W G Merz, C Hendricksen, et al.
Bone Marrow Transplantation|November 1, 1989
Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipientsJ R Wingard, E D Mellits, R J Jones, et al.
The New England Journal of Medicine|July 1, 1982
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipientsG V Quinnan, N Kirmani, A H Rook, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationL B Grochow, R J Jones, R B Brundrett, et al.
Pageof 15